Global Indoleamine 2,3 Dioxygenase 1 Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Indoleamine 2,3 Dioxygenase 1

• 1.1 Definition of Indoleamine 2,3 Dioxygenase 1
• 1.2 Indoleamine 2,3 Dioxygenase 1 Segment by Type
  • 1.2.1 Global Indoleamine 2,3 Dioxygenase 1 Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 BMS-986205
  • 1.2.3 Dcellvax
  • 1.2.4 Epacadostat
  • 1.2.5 F-001287
  • 1.2.6 Galanal
  • 1.2.7 Others
• 1.3 Indoleamine 2,3 Dioxygenase 1 Segment by Applications
  • 1.3.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Aolpecia
  • 1.3.3 Cervical Cancer
  • 1.3.4 Gastric Cancer
  • 1.3.5 Glioma
  • 1.3.6 Others
• 1.4 Global Indoleamine 2,3 Dioxygenase 1 Overall Market
  • 1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue (2014-2025)
  • 1.4.2 Global Indoleamine 2,3 Dioxygenase 1 Production (2014-2025)
  • 1.4.3 North America Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)
  • 1.4.4 Europe Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)
  • 1.4.5 China Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)
  • 1.4.6 Japan Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)
  • 1.4.8 India Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Indoleamine 2,3 Dioxygenase 1
• 2.3 Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase 1
• 2.4 Industry Chain Structure of Indoleamine 2,3 Dioxygenase 1

3 Development and Manufacturing Plants Analysis of Indoleamine 2,3 Dioxygenase 1

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Indoleamine 2,3 Dioxygenase 1 Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Indoleamine 2,3 Dioxygenase 1
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Indoleamine 2,3 Dioxygenase 1 Production and Capacity Analysis
• 4.2 Indoleamine 2,3 Dioxygenase 1 Revenue Analysis
• 4.3 Indoleamine 2,3 Dioxygenase 1 Price Analysis
• 4.4 Market Concentration Degree

5 Indoleamine 2,3 Dioxygenase 1 Regional Market Analysis

• 5.1 Indoleamine 2,3 Dioxygenase 1 Production by Regions
  • 5.1.1 Global Indoleamine 2,3 Dioxygenase 1 Production by Regions
  • 5.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Regions
• 5.2 Indoleamine 2,3 Dioxygenase 1 Consumption by Regions
• 5.3 North America Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.3.1 North America Indoleamine 2,3 Dioxygenase 1 Production
  • 5.3.2 North America Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Indoleamine 2,3 Dioxygenase 1 Import and Export
• 5.4 Europe Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.4.1 Europe Indoleamine 2,3 Dioxygenase 1 Production
  • 5.4.2 Europe Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Indoleamine 2,3 Dioxygenase 1 Import and Export
• 5.5 China Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.5.1 China Indoleamine 2,3 Dioxygenase 1 Production
  • 5.5.2 China Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Indoleamine 2,3 Dioxygenase 1 Import and Export
• 5.6 Japan Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.6.1 Japan Indoleamine 2,3 Dioxygenase 1 Production
  • 5.6.2 Japan Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Indoleamine 2,3 Dioxygenase 1 Import and Export
• 5.7 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.7.1 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Production
  • 5.7.2 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Import and Export
• 5.8 India Indoleamine 2,3 Dioxygenase 1 Market Analysis
  • 5.8.1 India Indoleamine 2,3 Dioxygenase 1 Production
  • 5.8.2 India Indoleamine 2,3 Dioxygenase 1 Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Indoleamine 2,3 Dioxygenase 1 Import and Export

6 Indoleamine 2,3 Dioxygenase 1 Segment Market Analysis (by Type)

• 6.1 Global Indoleamine 2,3 Dioxygenase 1 Production by Type
• 6.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type
• 6.3 Indoleamine 2,3 Dioxygenase 1 Price by Type

7 Indoleamine 2,3 Dioxygenase 1 Segment Market Analysis (by Application)

• 7.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption by Application
• 7.2 Global Indoleamine 2,3 Dioxygenase 1 Consumption Market Share by Application (2014-2019)

8 Indoleamine 2,3 Dioxygenase 1 Major Manufacturers Analysis

• 8.1 BirchBioMed Inc
  • 8.1.1 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.1.2 BirchBioMed Inc Product Introduction, Application and Specification
  • 8.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb Company
  • 8.2.1 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Ensemble Therapeutics Corp
  • 8.3.1 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.3.2 Ensemble Therapeutics Corp Product Introduction, Application and Specification
  • 8.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 F. Hoffmann-La Roche Ltd
  • 8.4.1 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.4.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
  • 8.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Genentech Inc
  • 8.5.1 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.5.2 Genentech Inc Product Introduction, Application and Specification
  • 8.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Globavir Biosciences Inc
  • 8.6.1 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.6.2 Globavir Biosciences Inc Product Introduction, Application and Specification
  • 8.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Incyte Corp
  • 8.7.1 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.7.2 Incyte Corp Product Introduction, Application and Specification
  • 8.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 IO Biotech ApS
  • 8.8.1 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.8.2 IO Biotech ApS Product Introduction, Application and Specification
  • 8.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Kyowa Hakko Kirin
  • 8.9.1 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.9.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
  • 8.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Netherlands Translational Research Center BV
  • 8.10.1 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Production Sites and Area Served
  • 8.10.2 Netherlands Translational Research Center BV Product Introduction, Application and Specification
  • 8.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 NewLink Genetics Corp
• 8.12 Pfizer Inc
• 8.13 Redx Pharma Plc
• 8.14 Regen BioPharma Inc

9 Development Trend of Analysis of Indoleamine 2,3 Dioxygenase 1 Market

• 9.1 Global Indoleamine 2,3 Dioxygenase 1 Market Trend Analysis
  • 9.1.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Indoleamine 2,3 Dioxygenase 1 Regional Market Trend
  • 9.2.1 North America Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
  • 9.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
  • 9.2.3 China Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
  • 9.2.4 Japan Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
  • 9.2.5 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
  • 9.2.6 India Indoleamine 2,3 Dioxygenase 1 Forecast 2019-2025
• 9.3 Indoleamine 2,3 Dioxygenase 1 Market Trend (Product Type)
• 9.4 Indoleamine 2,3 Dioxygenase 1 Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Indoleamine 2,3 Dioxygenase 1 Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List